FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

C Duba

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Genes & Molecular Sequences

Genes

Anatomy

Co-author Network

Publications

TOP 3
Thomas Kühr; Sonja Burgstaller; Ute Apfelbeck; Werner Linkesch; HL Seewann; Michael Fridrik; G Michlmayr; Otto Krieger; Dieter Lutz; W Lin; Jörg Pont; L Köck; K Abbrederis; Christian Baldinger; R Buder; D Geissler; Hubert Hausmaninger; A Lang; August Zabernigg; C Duba; Wolfgang Hilbe; Wolfgang Eisterer; Michael Fiegl; richard greil; Guenther Gastl; Josef Thaler
A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).
Wolfgang Hilbe; Thomas Kühr; Ute Apfelbeck; Michael Fridrik; HL Seewann; M Stöger; Werner Linkesch; Jörg Pont; Christian Baldinger; E Hartner; M Bernhart; D Geissler; Otto Krieger; A Lang; W Lin; Heinz Ludwig; C Duba; richard greil; G Gast; Josef Thaler
Dose escalation of ara-c may improve response rates in a subgroup of chronic myeloid leukemia patients with poor response to interferon-alpha and low-dose ara-C.
Thomas Kühr; Wolfgang Eisterer; Ute Apfelbeck; Werner Linkesch; Oliver E Bechter; August Zabernigg; K Geissler; G Barbieri; C Duba; Guenther Gastl; Josef Thaler
Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01): a pilot study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of C Duba (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: Thomas Kühr; Sonja Burgstaller; Ute Apfelbeck; Werner Linkesch; HL Seewann; Michael Fridrik; G Michlmayr; Otto Krieger; Dieter Lutz; W Lin; Jörg Pont; L Köck; K Abbrederis; Christian Baldinger; R Buder; D Geissler; Hubert Hausmaninger; A Lang; August Zabernigg; C Duba; Wolfgang Hilbe; Wolfgang Eisterer; Michael Fiegl; richard greil; Guenther Gastl; Josef Thaler
A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).
Leukemia research 2003;27(5):405-11.
2001: Wolfgang Hilbe; Thomas Kühr; Ute Apfelbeck; Michael Fridrik; HL Seewann; M Stöger; Werner Linkesch; Jörg Pont; Christian Baldinger; E Hartner; M Bernhart; D Geissler; Otto Krieger; A Lang; W Lin; Heinz Ludwig; C Duba; richard greil; G Gast; Josef Thaler
Dose escalation of ara-c may improve response rates in a subgroup of chronic myeloid leukemia patients with poor response to interferon-alpha and low-dose ara-C.
Leukemia & lymphoma 2001;42(6):1283-8.
2000: Thomas Kühr; Wolfgang Eisterer; Ute Apfelbeck; Werner Linkesch; Oliver E Bechter; August Zabernigg; K Geissler; G Barbieri; C Duba; Guenther Gastl; Josef Thaler
Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01): a pilot study.
Leukemia research 2000;24(7):583-7.
1998: Wolfgang Hilbe; Ute Apfelbeck; Michael Fridrik; M Bernhart; H Niessner; K Abbrederis; G Michlmayr; Jörg Pont; Werner Linkesch; Hubert Hausmaninger; K Arneitz; Christian Baldinger; C Duba; Wolfgang Eisterer; richard greil; Günther Konwalinka; Dietger Niederwieser; Guenther Gastl; Josef Thaler
Interferon-alpha for the treatment of elderly patients with chronic myeloid leukaemia.
Leukemia research 1998;22(10):881-6.
1997: Josef Thaler; Wolfgang Hilbe; Ute Apfelbeck; Werner Linkesch; Heinz Sill; HL Seewann; Jörg Pont; M Bernhart; M Stöger; H Niessner; K Abbrederis; D Geissler; Hubert Hausmaninger; W Lin; Heinz Ludwig; A Lang; C Duba; T Fluckinger; richard greil; Kurt Grünewald; Günther Konwalinka; Dietger Niederwieser; Michael Fridrik
Interferon-alpha-2C and LD ara-C for the treatment of patients with CML: results of the Austrian multi-center phase II study.
Leukemia research 1997;21(1):75-80.
1996: UO Nagl; Martin Erdel; A Schmarda; Marco Seri; Germar-M. Pinggera; Martin Gschwentner; C Duba; Luis J V Galietta; Peter Deetjen; Gerd Utermann; Markus Paulmichl
Chromosomal localization of the genes (CLNS1A and CLNS1B) coding for the swelling-dependent chloride channel ICln.
Genomics 1996;38(3):438-41.
1996: Josef Thaler; Guenther Gastl; T Fluckinger; Dietger Niederwieser; Heinz Huber; HL Seewann; Heinz Sill; A Lang; M Falk; C Duba; Gerd Utermann; Thomas Kühr; Walter Aulitzky; Christoph Huber
Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study. Austrian Biological Response Modifier (BRM) Study Group.
Annals of hematology 1996;72(6):349-55.
1995: Martin Erdel; Gabriele Baier-Bitterlich; C Duba; N Isakov; A Altman; Gerd Utermann; Gottfried Baier
Mapping of the human protein kinase C-theta (PRKCQ) gene locus to the short arm of chromosome 10 (10p15) by FISH.
Genomics 1995;25(2):595-7.
1994: Wolfgang Hilbe; Wolfgang Eisterer; C Schmid; I Starz; H Silly; C Duba; C Ludescher; Josef Thaler
Bone marrow lymphocyte subsets in myelodysplastic syndromes.
Journal of clinical pathology 1994;47(6):505-7.
1993: Josef Thaler; T Fluckinger; Heinz Huber; A Lang; C Abbrederis; HL Seewann; H Silly; C Baldinger; C Duba; Christoph Huber
Treatment of 11 patients with chronic myelogenous leukemia with interferon-alpha-2C and low-dose cytosine arabinoside.
Leukemia research 1993;17(8):711-5.
1991: Josef Thaler; Thomas Kühr; Guenther Gastl; Heinz Huber; C Duba; G Kemmler; C Gattringer; T Fluckinger; Dietger Niederwieser; HL Seewann
[Recombinant interferon alpha-2c in Ph-positive chronic myeloid leukemia. Results of a multicenter phase II study].
Deutsche medizinische Wochenschrift (1946) 1991;116(19):721-8.